IL4 and neoplasm: However, since the IL-4 DC vaccine only weakly recruits γδ T cells (20) and generally fails to potentiate γδ T cell functions (8), this missing interaction could aid to optimize DC vaccine immunopotency, promoting cytotoxic and long-lasting anti-tumor immunity.